Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2
MONDO:0014178Any inclusion body myopathy with Paget disease of bone and frontotemporal dementia in which the cause of the disease is a mutation in the HNRNPA2B1 gene.
Also known as: HNRNPA2B1 inclusion body myopathy with Paget disease of bone and frontotemporal dementia, inclusion body myopathy with Paget disease of bone and frontotemporal dementia caused by mutation in HNRNPA2B1, inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia type 2, IBMPFD2, multisystem Proteinopathy 2
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Smart sensors could revolutionize dementia monitoring at home
Knowledge-focused Not yet recruitingThis study will test if wearable sensors can effectively monitor symptoms and daily function in people with frontotemporal dementia (FTD). Sixty adults with FTD will wear pendant and wrist sensors for two weeks at a time, every six months over two years. The goal is to develop di…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Smart sensors could revolutionize how we track FTD symptoms
Knowledge-focused Not yet recruitingThis study tests whether wearable sensors and computerized voice and thinking tests can reliably track symptoms in people with frontotemporal dementia (FTD). Twenty participants will wear sensors and complete assessments at home over 12 months. The goal is to develop digital biom…
Sponsor: BioSensics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC